RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3062% above fair value
$74.92−1.97 (-2.56%)
Close on Nov 17, 2026Market cap $5.90BP/E –Yield –
RadNet price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
RadNet's price to book ratio was 5.6× on Nov 11, 2026, against 6.0× a year earlier. Over the last 5 years it ranged from 3.1× to 7.1×, with a median of 4.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.6× | +0.4 |
| 2025 | Dec 31, 2025 | 5.2× | −0.6 |
| 2024 | Dec 31, 2024 | 5.8× | +2.0 |
| 2023 | Dec 29, 2023 | 3.8× | +0.4 |
| 2022 | Dec 30, 2022 | 3.4× | −3.7 |
| 2021 | Dec 31, 2021 | 7.1× | +0.7 |
| 2020 | Dec 31, 2020 | 6.4× | −1.2 |
| 2019 | Dec 31, 2019 | 7.6× | +2.4 |
| 2018 | Dec 31, 2018 | 5.2× | −2.1 |
| 2017 | Dec 29, 2017 | 7.3× | −0.9 |
| 2016 | Dec 30, 2016 | 8.2× | −3.9 |
| 2015 | Dec 31, 2015 | 12.1× | −127.2 |
| 2014 | Dec 31, 2014 | 139.3× | −45.6 |
| 2013 | Dec 31, 2013 | 184.9× | – |
See a number that looks wrong?